WELLS FARGO & COMPANY/MN - EPIRUS BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 3 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$0
-100.0%
168
-29.1%
0.00%–
Q1 2016$1,0000.0%237
+2.6%
0.00%–
Q4 2015$1,0000.0%2310.0%0.00%–
Q3 2015$1,000
-66.7%
231
-49.1%
0.00%–
Q2 2015$3,000–454–0.00%–
 Download
Other shareholders

There were no reported owners of EPIRUS BIOPHARMACEUTICALS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders